NYSE · AACT
Ares Acquisition Corporation II
$9.49+$0.61 (+6.87%)
Ares Acquisition Corporation II’s quoted price sits in the lower half of its reported 52-week range, 18.33% below the high.
Loading market information…
NASDAQ · BCAC · USD
Stock price, earnings
Quote as of Aug 1, 2022, 04:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Brookline Capital Acquisition Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Brookline Capital Acquisition Corp., established in New York in 2020, currently maintains no active business operations. Instead, its primary objective is to complete a strategic business combination, such as a merger, asset acquisition, or stock purchase, with an existing company. The company specifically targets opportunities within the life sciences industry.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$9.49+$0.61 (+6.87%)
Ares Acquisition Corporation II’s quoted price sits in the lower half of its reported 52-week range, 18.33% below the high.
$10.88-$0.01 (-0.09%)
Sagaliam Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 7.14% below the high.
$13.12+$1.37 (+11.66%)
Rice Acquisition Corp. II’s quoted price sits in the lower half of its reported 52-week range, 23.68% below the high.
$14.15+$4.08 (+40.52%)
Decarbonization Plus Acquisition Corporation IV’s quoted price sits in the upper half of its reported 52-week range, 18.49% below the high.
$10.50+$0.03 (+0.29%)
Trine II Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 4.72% below the high.
$13.25+$2.19 (+19.8%)
Helix Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 12.31% below the high.
